Showing 31-40 of 1316 results for "".
Rosacea Comorbidities and Skincare with Energy-Based Devices
https://practicaldermatology.com/programs/practical-dermatology/rosacea-comorbidities-and-skincare-with-energy-based-devices/35895/Ted Lain, MD, MBA, discusses the gut-skin connection as it relates to rosacea, as well as skincare with energy-based devices, at Music City SCALE 2025.Cracking the Codes: Telemedicine Rolls Forward
https://practicaldermatology.com/topics/practice-management/cracking-the-codes-telemedicine-rolls-forward/23226/Here’s a primer on the new online digital E/M service codes.“No Drug is 100 Percent.”
https://practicaldermatology.com/conferences/maui-derm-2024/no-drug-is-100-percent/20242/Jason Hawkes, MD and Chief Medical Editor Neal Bhatia, MD discuss how the current array of options for patients of chronic spontaneous urticaria (CSU) expand treatment options for hives beyond antihistamines.Urticaria: Dr. Hawkes
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/urticaria-dr-hawkes/32690/Jason Hawkes, MD, talks about how to manage and approach chronic spontaneous urticaria patients, as well as novel therapeutic options, all of which he covered in "Urticaria Update 2025" at Maui Derm 2025.Meeting the Needs of Today's Injectables Market
https://practicaldermatology.com/series/c-suite-chats/meeting-needs-todays-injectables-market/26926/David Moatazedi, president and CEO of Evolus, talks about trends in the injectables market and the needs of younger generations.Improving Treatment Capabilities for Vitiligo
https://practicaldermatology.com/series/c-suite-chats/improving-treatment-capabilities-for-vitiligo/29745/David Domzalski, CEO and President of Vyne Therapeutics, discusses what makes vitiligo difficult to treat and how his company is working to address those challenges.Assessing the Aging Face
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/assessing-the-aging-face/18849/Jason Emer, MD discusses the evolving filler market and new trends in facial rejuvenation treatments. He offers tips for assessing patients globally—in three and four dimensions—in order to choose the right options for contouring the face with fillers and fat in order to give patients the most naturA Broad View of the Current Literature
https://practicaldermatology.com/conferences/maui-derm-2024/a-broad-view-of-the-current-literature/20263/Resident Of Distinction Award-winner Jason Klein, MD, PhD, a dermatology resident at the UT Southwestern Medical Center, talks about some of the latest developments in dermatology literature highlighted in review presentations at Maui Derm 2024, including an elegant synopsis of current options for tIntroduction to Nutraceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/introduction-to-nutraceuticals/18438/What are nutraceuticals and what role may they play in surgical outcomes? Why should aesthetic surgeons care about nutrition? Jason Bloom, MD discusses the rationale behind nutraceuticals to support surgical outcomes and describes his observations after recommending a formulation to his patients.Journal Club: What's New in Pathogenesis and Treatment of Atopic Dermatitis
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-whats-new-in-pathogenesis-and-treatment-of-atopic-dermatitis/26247/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Jason E. Hawkes, MD, a dermatologist practicing in the Sacramento area, and a member of the Practical Dermatology Editorial Board, about the latest research on the pathogenesis of and treatment targets for atopic dermatitis (AD).